Discover
BVS
Bioventus Inc.
10.20
1 x 7.34
1 x 12.96
bid
ask
+
0.35
3.58%
12:13 PM
timesize
| Ytd | 37.13% | |
| 1y | 48.94% |
9.88
day range
10.21
5.81
52 week range
11.25
| Open | 9.97 | Prev Close | 9.85 | Low | 9.88 | High | 10.21 | Mkt Cap | 691.03M |
| Vol | 285.94K | Avg Vol | 600.01K | EPS | 0.41 | P/E | 24.88 | Forward P/E | 16.14 |
| Beta | 0.88 | Short Ratio | 2.45 | Inst. Own | 69.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 9.55 | 200-d Avg | 8.28 | 1yr Est | 15.00 |
| Income Statement | |||
| Total Revenue | 132.09M | ||
| Revenues (USD) | 132.09M | ||
| Cost of Revenue | 41.32M | ||
| Gross Profit | 90.77M | ||
| Operating Expenses | 86.25M | ||
| Research and Development Expense | 2.47M | ||
| Selling, General and Administrative Expense | 78.33M | ||
| Operating Income | 4.52M | ||
| Interest Expense | 4.33M | ||
| Income Tax Expense | 571.00K | ||
| Net Income | 3.11M | ||
| Net Income Common Stock | 3.11M | ||
| Net Income Common Stock (USD) | 3.11M | ||
| Consolidated Income | 3.95M | ||
| Net Income to Non-Controlling Interests | 833.00K | ||
| Earnings per Basic Share | 0.05 | ||
| Earnings per Basic Share (USD) | 0.05 | ||
| Earnings per Diluted Share | 0.04 | ||
| Earning Before Interest & Taxes (EBIT) | 8.01M | ||
| Earning Before Interest & Taxes (USD) | 8.01M | ||
| Weighted Average Shares | 67.30M | ||
| Weighted Average Shares Diluted | 70.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 35.85M | ||
| Cash and Equivalents (USD) | 35.85M | ||
| Investments | 2.10M | ||
| Investments Non-Current | 2.10M | ||
| Trade and Non-Trade Receivables | 120.53M | ||
| Current Assets | 249.81M | ||
| Property, Plant & Equipment Net | 25.98M | ||
| Total Assets | 650.54M | ||
| Debt Current | 18.75M | ||
| Total Debt | 272.08M | ||
| Current Liabilities | 148.10M | ||
| Debt Non-Current | 253.33M | ||
| Total Liabilities | 416.27M | ||
| Accumulated Retained Earnings (Deficit) | -331.82M | ||
| Accumulated Other Comprehensive Income | -2.28M | ||
| Shareholders Equity | 188.90M | ||
| Shareholders Equity (USD) | 188.90M | ||
| Assets Non-Current | 400.73M | ||
| Total Debt (USD) | 272.08M | ||
| Goodwill and Intangible Assets | 367.12M | ||
| Inventory | 83.19M | ||
| Liabilities Non-Current | 268.18M | ||
| Trade and Non-Trade Payables | 24.05M | ||
| Tax Assets | 5.52M | ||
| Tax Liabilities | 568.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.21M | ||
| Net Cash Flow from Financing | -23.14M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -15.39M | ||
| Capital Expenditure | -574.00K | ||
| Issuance (Purchase) of Equity Shares | 120.00K | ||
| Issuance (Repayment) of Debt Securities | -22.00M | ||
| Net Cash Flow from Investing | -574.00K | ||
| Net Cash Flow from Operations | 8.93M | ||
| Effect of Exchange Rate Changes on Cash | -608.00K | ||
| Share Based Compensation | 3.26M | ||